Protecting its interests: FDA attacks CBD supplements to protect Big Pharma’s opioid profits

Big Pharma is working overtime to restrict consumer access to cannabidiol, or CBD, a non-psychoactive component of cannabis sativa (marijuana) that’s been shown to help relieve pain, muscle spasms, and other ailments. Using the U.S. Food and Drug Administration (FDA) as authoritative cover, the industry is quietly leading the charge to ban CBD from being used in dietary supplements, even though the substance is completely natural and offers numerous health benefits while causing no harmful side effects.